Lena Gray, P.T. &
Baby Development Expert
A B O U T E D 3
Deerfield Management Company and the Empire Discovery Institute (EDI) have formed a translational research partnership to accelerate the development of novel therapeutics. Through the partnership Deerfield expects to invest up to $65 million over the next five years to translate scientific discoveries with potential applications for patients.
Through a newly launched company called Empire Deerfield Discovery & Development LLC (ED3 ), funding and support will be available for projects in high-need therapeutic areas, as well as those targeting patients who suffer from hard-to-treat and rare diseases, to accelerate them towards clinical validation in patients and commercialization.
G E N E R A L I N Q U I R I E S
ED3 is accepting general inquiries and letters of intent (LOI's) from research investigators and faculty members at the University of Rochester, the University at Buffalo, and Roswell Park Comprehensive Cancer Center. Interested parties should contact their local Technology Transfer Office about their interest in ED3 and to verify that their program is available for licensing.
FOR MORE INFORMATION, PLEASE CONTACT
Ron Newbold, PhD
MEET OUR PARTNERING TEAM
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
EMPIRE DISCOVERY INSTITUTE
Transforming Discoveries into Medicines
Empire Discovery Institute EDI is a non-profit New York drug discovery and development accelerator created to translate important academic discoveries into new medicines for commercialization by providing strategic support and pharmaceutical development expertise. EDI works in partnership with research labs at the University of Rochester, the University at Buffalo, and Roswell Park Comprehensive Cancer Center.
Empire Discovery Institute and Deerfield Management Launch Empire-Deerfield Discovery & Development (ED3) LLC